Ackman Says Valeant No ‘Bad Rollup Co.’

Jun 9 2014 | 10:42am ET

Pershing Square Capital Management founder William Ackman took to the airwaves to defend Valeant Phamaceuticals International’s bid for Allergan Inc.—and the company itself.

Ackman told CNBC that the major shareholders he met with last week said they would support a bid for $180 per Allergan share—roughly the value of Allergan’s latest offer. And he rejected Allergan’s contention that Valeant is nothing more than a “serial acquirer” whose strategy is unsustainable.

“A bad rollup is a company that uses an over-inflated stock price and a high multiple and non-cash GAAP earnings, heavily promoted by a CEO, to acquire companies at lower multiples,” Ackman said. By contrast, Valeant is more like Berkshire Hathaway, “Colgate or Procter & Gamble.” And he turned the tables on Allergan’s contention that it is more research-and-development-focused than Valeant, noting that Allergan acquired its flagship product, Botox.

“Those kind of finding alternative therapeutic uses—extending the life of the product—that is very cost-effective R&D” and very similar to Valeant, Ackman said.

Ackman also discussed his continuing short bet against Herbalife Inc., noting that Pershing Square is down, but poised to make a $2 billion profit should federal regulators shut the nutritional supplements company down. And he said he’d like to see his former bitter rival sell his holdings of the company.

“I’d love to find” Carl Icahn “a way out of Herbalife, because I think if he could get out now he’d have a very nice profit,” Ackman said. And he credited his Valeant-Allergan play with brining about his rapprochement with Icahn.

“We had a year of sort of hating each other,” Ackman said. But Icahn “was very sweet to me on your network” about Valeant, leading to the phone call that ended their feud.


In Depth

Q&A: Open Season For Closed-End Funds

Aug 29 2014 | 10:00am ET

When Maury Fertig and Bob Huffman, former Salomon Brothers coworkers, launched...

Lifestyle

Och Funds Women In Finance Initiative At U-M

Aug 28 2014 | 3:01pm ET

Och-Ziff Capital founder Daniel Och and his wife have made a "generous donation"...

Guest Contributor

Looking Ahead: What’s In Store For Managed Futures?

Aug 22 2014 | 12:52pm ET

The last five years were phenomenal for investors in equity indices. Will the next...

 

Editor's Note

    Get A Sneak Peak Of The Alpha Pages

    Aug 25 2014 | 11:21am ET

    As many of you know, FINalternatives was recently acquired by the owners of Futures magazine, a firm called The Alpha Pages LLC. Today marks the soft-launch of a new sister site for both publications. As its name suggests, The Alpha Pages will cover all types of alternative investments, going far beyond the more well-known ones such as hedge funds and private equity. Read more…

 

Futures Magazine

July/August 2014 Cover

The time was right

Commodities/Futures magazine launched at the precipice of a revolution in the futures industry—really a revolution in the idea of risk management—that would move it from a small niche industry to ...

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.